Nuwellis (NUWE) Net Income towards Common Stockholders (2011 - 2026)
Nuwellis' (NUWE) quarterly Net Income towards Common Stockholders came in at -$4.5 million in Q1 2026, down 50.65% YoY from -$9.2 million in Q1 2025, and down 87.48% on a QoQ basis from -$2.4 million in Q4 2025.
Nuwellis (NUWE) Net Income towards Common Stockholders (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has 16 years of Net Income towards Common Stockholders data on file, last reported at -$4.5 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 50.65% year-over-year to -$4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.0 million (down 93.37% YoY) and the FY2025 annual result came in at -$17.5 million, down 64.88% from the prior year.
- Net Income towards Common Stockholders eased to -$4.5 million in Q1 2026, from -$2.4 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $2.4 million in Q3 2024 to a low of -$12.6 million in Q2 2025.
- A 5-year average of -$4.1 million and a median of -$3.9 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders sank 476.93% — and 2024, when it surged 169.97%.
- Tracing NUWE's Net Income towards Common Stockholders over 5 years: stood at -$1.4 million in 2022, then slumped by 476.93% to -$7.9 million in 2023, then soared by 81.48% to -$1.5 million in 2024, then sank by 64.92% to -$2.4 million in 2025, then plunged by 87.48% to -$4.5 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$4.5 million (Q1 2026), -$2.4 million (Q4 2025), and $469000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Nuwellis | 204,804.59 | -3.72 Mn | 1.50 Mn | -4.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.83 Mn |
| Mar 31, 2026 | -4.54 Mn |
| Dec 31, 2025 | -2.42 Mn |
| Sep 30, 2025 | 469,000.00 |
| Jun 30, 2025 | -12.55 Mn |
| Mar 31, 2025 | -3.01 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | -7.73 Mn |
| Mar 31, 2024 | -3.79 Mn |
| Dec 31, 2023 | -7.93 Mn |
| Sep 30, 2023 | -3.37 Mn |
| Jun 30, 2023 | -4.85 Mn |
| Mar 31, 2023 | -6.49 Mn |
| Dec 31, 2022 | -1.37 Mn |
| Sep 30, 2022 | -3.87 Mn |
| Jun 30, 2022 | -4.29 Mn |
| Mar 31, 2022 | -4.47 Mn |
| Dec 31, 2021 | 15.82 Mn |
| Sep 30, 2021 | -5.27 Mn |